Has been tested with anti-influenza B monoclonal antibodies in ELISA.
Serological studies of influenza B virus, immunogen for antibody production.
-20 degrees C
0.005% merthiolate This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques is required at work.
Supplied as a liquid in STE containing 0.1% sodium azide and 0.005% merthiolate.
Purified by ultracentrifugation using 10-40% sucrose gradient. (same/more than) 90% (SDS-PAGE).
Biosave is the leading savings website for Life Scientists. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else!